Internal Medicine
Opinion | Covid-19 vaccine passports will harm sustainable development
31 Mar, 2021 | 03:31h | UTCCovid-19 vaccine passports will harm sustainable development – The BMJ Opinion
“Where you are born can predict how freely you will be able to travel for opportunity, education, and leisure. Being a citizen of certain countries grants people access to nearly the entire globe, whereas others face challenges just to legally leave the borders of the country they live in”
Opinion | Covid-19 vaccine passports and vaccine hesitancy: freedom or control?
31 Mar, 2021 | 03:29h | UTCCovid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion
“Recent debates around “vaccine passports,” or formal/mandatory certification of vaccination, point towards a potential widening societal divide between those who are vaccinated and those who are not.”
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
30 Mar, 2021 | 03:08h | UTCNews Release: Six pregnancy complications are among red flags for heart disease later in life – American Heart Association
Troponin Testing in Patients With Supraventricular Tachycardia—Are We Overtesting? A Teachable Moment
30 Mar, 2021 | 03:07h | UTCTroponin Testing in Patients With Supraventricular Tachycardia—Are We Overtesting? A Teachable Moment – JAMA Internal Medicine (free for a limited period)
Invited Commentary: Updating Our Thinking on Troponin Use and Interpretation (free for a limited period)
Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine
30 Mar, 2021 | 02:53h | UTC
Commentary on Twitter (thread – click for more)
We've just published in @Clin_Med our analysis of financial conflicts of interest (CoIs) amongst the authors of 5 ESC Guidelines. What we found was quite surprising. We would love to know what you all think!https://t.co/U371ROXGAv
Let's start with a poll 👇🏽
— Benoy Shah MD (@dr_benoy_n_shah) March 28, 2021
Controversies in revascularization for stable coronary artery disease
30 Mar, 2021 | 02:49h | UTCControversies in revascularisation for stable coronary artery disease – Clinical Medicine Journal
The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician
30 Mar, 2021 | 02:51h | UTC
‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective
30 Mar, 2021 | 03:27h | UTC‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective – STAT
Commentary on Twitter (thread – Click for more)
https://twitter.com/hildabast/status/1376648088878608386
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
30 Mar, 2021 | 03:21h | UTC
COVID-19, Personal Protective Equipment, and Human Performance
30 Mar, 2021 | 03:14h | UTCCOVID-19, Personal Protective Equipment, and Human Performance – Anesthesiology
COVID associated with hearing loss, tinnitus and vertigo – new study confirms link
30 Mar, 2021 | 03:19h | UTCOriginal study: One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms – International Journal of Audiology
Cochrane Library Editorial: Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19
28 Mar, 2021 | 22:55h | UTCCommentary and Infographic: Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus? – Cochrane Library
Original review: Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19 – Cochrane Library
Commentary on Twitter
New #VisualAbstract for the @Cochrane_IDG systematic review on #Chloroquine or #hydroxychloroquine for prevention and treatment of #COVID19 https://t.co/U7TnMzQTil Many thanks to @tylerdau & @cg_coleman from @EmoryMedicine pic.twitter.com/tlFKKa31E8
— The Cochrane Library (@CochraneLibrary) March 25, 2021
RCT: Discontinuing betalactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards
28 Mar, 2021 | 22:25h | UTC
Commentary on Twitter
Less can be more for pneumonia. In 50% CAP patients was possible stop Abx at 3 days and outcomes were the same @TheLancet https://t.co/Hc1AxyndWS pic.twitter.com/Ypk2uXeDQV
— Michael Marks (@dr_michaelmarks) March 26, 2021
Long term outcomes of participants in the PARAMEDIC2 randomized trial of adrenaline in out-of-hospital cardiac arrest – although survival was improved, adrenalin was not associated with favorable neurologic outcomes
28 Mar, 2021 | 22:21h | UTCCommentary: PARAMEDIC2 – Epinephrine vs Placebo OHCA 6-12 Months – Journal Feed
Original study: Randomized Trial: Epinephrine in Out-of-Hospital Cardiac Arrest (study and commentaries) AND Opinion: Epinephrine Harms/Helps in Out of Hospital Cardiac Arrest
NICE Guideline Update: Cannabis-based medicinal products
28 Mar, 2021 | 22:24h | UTCCannabis-based medicinal products – National Institute for Health and Care Excellence
Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination
28 Mar, 2021 | 22:53h | UTC
Commentaries on Twitter
Now a peer-reviewed pub in a top journal, this elegant study clearly shows that variant B.1.351 isn't stopped by antibodies from prior infection or the Pfizer vax. We'll have revised vaccines, but we don't yet. Please behave accordingly. https://t.co/w8GHPDB7aL
— EQV Analytics 🇺🇦😷🔬🪷 (@AnalyticsEqv) March 27, 2021
New @NatureMedicine, further data on immune response after vaccination to 2 variants, B.1.1.7 (UK) and B.1.351 (SA). Reinforcing recent reports, the latter is more of an immune evader, and may pose vulnerability for reinfection post-vaccinehttps://t.co/w8xFc3fkh5 pic.twitter.com/i7DAnjSZwE
— Eric Topol (@EricTopol) March 26, 2021
Editorial | Remote by default general practice: must we, should we, dare we?
28 Mar, 2021 | 22:18h | UTC
https://twitter.com/trishgreenhalgh/status/1375408196303650818
Opinion | Understanding of research results, evidence summaries and their applicability—not critical appraisal—are core skills of medical curriculum
28 Mar, 2021 | 22:16h | UTC
Commentaries on Twitter
Excellent 2-pager on prioritising understanding of results over critical appraisal in EBM training. (Note: I want both, but understanding results should be first). @LoaiAlbarqouni @Tammy_Hoffmann have experimented with that. https://t.co/Fd88xaqgOu pic.twitter.com/0LYnmUmD4K
— Paul Glasziou (@PaulGlasziou) March 18, 2021
We argue (with Gordon Guyatt) that evidence based medicine educators should spend much more time & emphasis on understanding of magnitude of effect & applicability of results; less time & emphasis to risk of bias in primary studies. Open access at https://t.co/E7NjzJwFxP #EBM pic.twitter.com/nMXp8hVzHb
— Kari Tikkinen (@KariTikkinen) March 18, 2021
Just published, exhorting the #EBM community to wake up to the fact that our teaching should focus on helping clinicians understand research results, not on conducting critical appraisal. @KariTikkinen https://t.co/07Hm8aSnAI pic.twitter.com/m2RWrBvCVT
— Gordon H. Guyatt (@GuyattGH) March 22, 2021
Really interesting article in BMJ EBM. Are we prioritising the wrong things in critical appraisal training? "Understanding of research results, evidence summaries and their applicability—not critical appraisal—are core skills of medical curriculum" https://t.co/gXk1zLVUX8
— MPFT Library (@library_mpft) March 23, 2021
Junior doctors *usually* rely on guidelines/evidence summaries, NOT primary research studies.
"….notion that most clinicians emerging from professional training will regularly evaluate the risk of bias in methods and results of primary studies is deluded."
Seems fair enough… https://t.co/prv2ZuZ6Yp— David Henshall (@DavidHenshall_) March 22, 2021
Quadrivalent influenza nanoparticle vaccines induce broad protection against a wide variety of seasonal and pandemic influenza strains in animal models
28 Mar, 2021 | 22:01h | UTCQuadrivalent influenza nanoparticle vaccines induce broad protection – Nature
Commentary: Nanoparticle flu vaccine blocks seasonal and pandemic strains – University of Washington School of Medicine
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
28 Mar, 2021 | 22:49h | UTCCovid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ
Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion
How COVID-19 Affects the Brain
28 Mar, 2021 | 22:51h | UTCHow COVID-19 Affects the Brain – JAMA Psychiatry
Commentary on Twitter
#COVID19 brain symptoms are a rising concern. Mechanisms of brain damage by the virus include lasting neuroinflammation, thrombotic events and alteration of neurotransmitters release. Consequently, people suffer cognitive, emotional and behavioral symptoms https://t.co/pTzJo6DLV8
— JAMA Psychiatry (@JAMAPsych) March 26, 2021
Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far
28 Mar, 2021 | 22:46h | UTCThe Coronavirus Variants Don’t Seem to Be Highly Variable So Far – Scientific American
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
28 Mar, 2021 | 22:48h | UTCCommentary: 85% of COVID-19 long-haulers have multiple brain-related symptoms – LiveScience AND ‘Brain fog’ and other neurologic symptoms can last for months after Covid – NBC News AND Neurologic Symptoms Persistent for Many COVID-19 ‘Long-Haulers’ – Health Day
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
28 Mar, 2021 | 22:40h | UTCInterleukin‐6 blocking agents for treating COVID‐19: a living systematic review – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1375456773486874628
Opinion | COVID-19 Is Different Now: The coronavirus is changing. So is the disease it causes.
28 Mar, 2021 | 22:44h | UTCCOVID-19 Is Different Now – The Atlantic